<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
  <channel>
    <title>Evidence Change Feed</title>
    <link>https://nextconsensus.com/evidence-change/</link>
    <description>A dated, sourced record of changes in guideline, regulatory, and payer evidence, positioned on the recognition ladder (rungs 5–7). The feed is a public record, not a forecast.</description>
    <lastBuildDate>Fri, 31 Jul 2026 00:00:00 GMT</lastBuildDate>
    <language>en</language>
  <item>
    <title>NCCN adds free weekly guideline-change updates</title>
    <link>https://www.nccn.org/home/news/newsdetails?NewsId=5551</link>
    <guid isPermaLink="false">nccn-guidelines-weekly-updates</guid>
    <pubDate>Fri, 01 May 2026 00:00:00 GMT</pubDate>
    <description>NCCN introduced a free Guidelines Weekly Updates email alongside a paid Flash Updates tier, publishing what changed across its guideline library on a fixed cadence.</description>
  </item>
  <item>
    <title>FDA finalizes guidance on communicating scientific information about unapproved uses</title>
    <link>https://www.fda.gov/media/184871/download</link>
    <guid isPermaLink="false">fda-siuu-guidance</guid>
    <pubDate>Tue, 07 Jan 2025 00:00:00 GMT</pubDate>
    <description>FDA published its final guidance describing how firms may communicate truthful, non-misleading scientific information about unapproved uses, including requirements to keep sources unaltered, complete, and conflict-disclosed.</description>
  </item>
  <item>
    <title>ICER publishes annual Launch Price and Access Report</title>
    <link>https://icer.org/</link>
    <guid isPermaLink="false">icer-launch-price-access-report</guid>
    <pubDate>Wed, 01 Oct 2025 00:00:00 GMT</pubDate>
    <description>ICER released its annual review of launch prices and access conditions — an independent, conflict-disclosed assessment of how new products enter coverage.</description>
  </item>
  </channel>
</rss>
